Repligen RGEN
NASDAQ RGEN
$181.29 +1.01 (+0.56%)
As of: Aug 21, 2026 · 1:51 PM EDT

Repligen (RGEN) Restructuring Costs (2012 - 2026)

Repligen (RGEN) posted quarterly Restructuring Costs of $2.7 million for Q2 2026, up 25.72% year-over-year from $2.2 million in Q2 2025, and up 81.68% quarter-over-quarter from $1.5 million in Q1 2026.

Repligen (RGEN) Restructuring Costs (2012 - 2026) Analysis & Trends

Repligen (RGEN) has reported Restructuring Costs for 5 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Restructuring Costs rose 25.72% year-over-year to $2.7 million; the TTM figure through Jun 2026 stood at $8.3 million (up 37.09% YoY), while the FY2014 annual figure was $1.9 million, up 2032.89% from the prior year.
  • Restructuring Costs climbed to $2.7 million in Q2 2026 per RGEN's latest filing, from $1.5 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $2.7 million in Q2 2026 and bottomed at $1.5 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.49 Bn 129.28 Bn 1.96 Bn
2 Becton Dickinson 52.54 Bn 51.67 Bn 2.32 Bn
3 Alcon 35.71 Bn 34.35 Bn 1.68 Bn
4 Resmed 33.80 Bn 32.33 Bn 861.22 Mn
5 Medline 29.08 Bn 26.40 Bn 2.22 Bn
6 West Pharmaceutical Services 24.96 Bn 24.52 Bn 329.20 Mn
7 Solventum 15.40 Bn 15.00 Bn 1.29 Bn
8 Cooper Companies 14.82 Bn 14.68 Bn 735.40 Mn
9 Baxter International 13.61 Bn 11.46 Bn 1.03 Bn
10 Repligen 10.22 Bn 9.21 Bn 110.04 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.72 Mn
Mar 31, 2026 1.50 Mn
Jun 30, 2025 2.16 Mn
Mar 31, 2025 1.97 Mn
Dec 31, 2014 1.95 Mn
Sep 30, 2014 10,000.00
Jun 30, 2014 18,000.00
Mar 31, 2014 98,000.00
Dec 31, 2013 45,000.00
Sep 30, 2013 65,000.00
Jun 30, 2013 35,000.00
Mar 31, 2013 -54,000.00
Dec 31, 2012 267,000.00
Sep 30, 2012 344,000.00